Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide. Berberine (BBR), a bioactive monomer derived from traditional Chinese medicine, demonstrates remarkable multi-target pharmacological properties in regulating glucose and lipid metaboli...